GW&K Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
2,083
+41
| +2% | +$4.41K | ﹤0.01% | 371 |
|
|
2025
Q1 | $206K | Buy |
2,042
+15
| +0.7% | +$1.51K | ﹤0.01% | 375 |
|
|
2024
Q4 | $181K | Buy |
2,027
+6
| +0.3% | +$536 | ﹤0.01% | 375 |
|
|
2024
Q3 | $169K | Buy |
2,021
+233
| +13% | +$19.5K | ﹤0.01% | 368 |
|
|
2024
Q2 | $138K | Buy |
1,788
+159
| +10% | +$12.3K | ﹤0.01% | 371 |
|
|
2024
Q1 | $112K | Buy |
1,629
+811
| +99% | +$55.8K | ﹤0.01% | 369 |
|
|
2023
Q4 | $47K | Buy |
818
+2
| +0.2% | +$115 | ﹤0.01% | 413 |
|
|
2023
Q3 | $43K | Buy |
816
+343
| +73% | +$18.1K | ﹤0.01% | 405 |
|
|
2023
Q2 | $26K | Buy |
+473
| New | +$26K | ﹤0.01% | 444 |
|
|
2022
Q3 | – | Sell |
-88
| Closed | -$3K | – | 456 |
|
|
2022
Q2 | $3K | Sell |
88
-24
| -21% | -$818 | ﹤0.01% | 672 |
|
|
2022
Q1 | $5K | Buy |
+112
| New | +$5K | ﹤0.01% | 533 |
|